Literature DB >> 14751190

Stage II-B carcinoma of the cervix complicated by bilateral pelvic kidneys.

Ted M Roth1, Casey T Woodring, Ramon P McGehee.   

Abstract

BACKGROUND: The simultaneous occurrence of advanced cervical cancer and a pelvic kidney is uncommonly reported. It is an interesting clinical problem because the pelvic kidney lies within the radiation field. CASE: A patient found to have bilateral pelvic kidneys and stage II-B cervical cancer underwent an anterior exenteration. This was complicated by urinary conduit leakage and eventual nephrectomy for hemorrhage. She has been followed for 14 months with normal renal function and no evidence of disease.
CONCLUSION: A primary surgical approach to stage II-B cervical carcinoma was offered to this patient because of bilateral pelvic kidneys. Anastomotic breakdown with urinary leakage after an ileal conduit remains a significantly morbid problem.

Entities:  

Mesh:

Year:  2004        PMID: 14751190     DOI: 10.1016/j.ygyno.2003.09.033

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Approach to carcinoma cervix with pelvic kidney.

Authors:  Rajaraman Ramamurthy; Vimalakannan Muthusamy; Syed Afroze Hussain
Journal:  Indian J Surg Oncol       Date:  2011-03-25

2.  Intensity Modulated Radiotherapy (IMRT) in the postoperative treatment of an adenocarcinoma of the endometrium complicated by a pelvic kidney.

Authors:  Marcus S Castilho; Alexandre A Jacinto; Gustavo A Viani; Andre Campana; Juliana Carvalho; Robson Ferrigno; Paulo E R S Novaes; Ricardo C Fogaroli; Joao V Salvajoli
Journal:  Radiat Oncol       Date:  2006-11-20       Impact factor: 3.481

3.  Total Exenteration En Bloc with a Nephrectomy for Locally Advanced Cervical Cancer Invading a Pelvic Kidney-a Case Report and Literature Review.

Authors:  Nicolae Bacalbasa; Irina Balescu; Mihaela Vilcu; Simona Dima; Camelia Diaconu; Laura Iliescu; Alexandru Filipescu; Iulian Brezean
Journal:  Medicina (Kaunas)       Date:  2020-01-15       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.